Cargando…
1671MO Provision of palliative care for patients with cancer and SARS-CoV-2 infection
Autores principales: | Soosaipillai, G.B., Sureda, A., Maluquer Artigal, C., Benafif, S., Chopra, N., Harbeck, N., Wuerstlein, R., Mesia Nin, R., Felip, E., Ottaviani, D., Galazi, M., Lee, A.J.X., Salazar, R., Sharkey, R., Reyes, R., Evans, J., Carmona Garcia, M.C., Tabernero, J., Prat, A., Pinato, D.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506333/ http://dx.doi.org/10.1016/j.annonc.2020.08.1736 |
Ejemplares similares
-
1704P COVID-19 mortality in patients receiving anti-cancer therapy in a UK national cancer centre
por: Wu, A., et al.
Publicado: (2020) -
1734P Do cancer patients really do worse? A study in a UK tertiary hospital within a COVID-19 epicentre
por: Sng, C.C.T., et al.
Publicado: (2020) -
1575P Systemic anti-cancer therapy and metastatic cancer are independent mortality risk factors during two UK waves of the COVID-19 pandemic at University College London Hospital
por: Sinclair, A., et al.
Publicado: (2021) -
318O Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients
por: Pinato, D.J., et al.
Publicado: (2020) -
Cancer History and Systemic Anti-Cancer Therapy Independently Predict COVID-19 Mortality: A UK Tertiary Hospital Experience
por: Sng, Christopher C. T., et al.
Publicado: (2020)